(RTTNews) - Corvus Pharmaceuticals, Inc. (CRVS) announced positive results from Cohort 4 of its placebo-controlled Phase 1 clinical trial evaluating Soquelitinib, the company's lead ITK inhibitor, in ...

In study after study where researchers tracked participants’ hobbies over 10 or 15 years, people with a dancing hobby did better, she told The Washington Post: “They have less risk of developing heart ...

The biggest stories of the day delivered to your inbox.

Austin drivers have been dealing with construction delays on Loop 360 will get some relief next year, but a new project kicks off in 2026. A key nuclear weapons treaty is ending. It’s a blow to Russia ...

Fluor and JGC said Monday they had handed over LNG Canada's second production train, bringing the Shell-led project's capacity to 14 million tons a year. Image by MikeMareen via iStock Fluor Corp and ...

Moviefone recently had the pleasure of speaking with Michelle Pfeiffer and Felicity Jones about their work on 'Oh. What. Fun.', Pfeiffer’s first reaction to the screenplay, making a Christmas movie ...

Enbridge plans to invest approximately $1.4 billion in the project, adding 150 kbpd of capacity to the Mainline system and 100 kbpd to the FSP. The company expects the new capacity to come online in ...

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...

Researchers at the quantum computing firm Quantinuum used a new Helios-1 quantum computer to simulate a mathematical model that has long been used to study superconductivity. These simulations are not ...

PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics today announced the launch of a Phase 1, dose-escalating trial of STM-01, Secretome’s neonatal cardiac progenitor cell (nCPC) product, for the ...